Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCC9 | O60706 | 1/20 | 0.32 |
| ▸ | ABCC8 | Q09428 | 1/20 | 0.32 |
| ▸ | KCNJ11 | Q14654 | 1/20 | 0.32 |
| ▸ | KCNJ8 | Q15842 | 1/20 | 0.32 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.31 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.31 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TTR | P02766 | 1/20 | 0.30 |
| ▸ | ALB | P02768 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21962157 | 0.81 | PTGDR2 (0.35) | ABCC9ABCC8KCNJ11KCNJ8GPR35 | |
| SCHEMBL25138912 | 0.79 | EGFR (0.33) | ABCC9ABCC8KCNJ11KCNJ8GRIN1 | |
| SCHEMBL25139005 | 0.79 | ABCC9 (0.32) | ABCC9ABCC8KCNJ11KCNJ8CYP2A6 | |
| SCHEMBL25139126 | 0.78 | EGFR (0.30) | ABCC9ABCC8KCNJ11KCNJ8 | |
| SCHEMBL22705097 | 0.78 | CYP2A6 (0.39) | GPR35CYP2A6ALDH1A1TTRALB | |
| SCHEMBL23692165 | 0.77 | GPR35 (0.31) | GPR35ALDH1A1 | |
| SCHEMBL22014711 | 0.74 | HTT (0.38) | ABCC9ABCC8KCNJ11KCNJ8GRIN1 | |
| SCHEMBL22014713 | 0.74 | ABCC9 (0.34) | ABCC9ABCC8KCNJ11KCNJ8GRIN1 | |
| SCHEMBL22014712 | 0.74 | ALDH1A1 (0.34) | ABCC9ABCC8KCNJ11KCNJ8GPR35 | |
| SCHEMBL2154082 | 0.73 | TTR (0.35) | CYP2A6ALDH1A1TTRALB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020102574-A1 | THE COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY | NOVARTIS INFLAMMASOME RESEARCH, INC. (US) | 2020-05-22 | — | — | WO | disclosed |